About LynxDx
LynxDx is a Healthcare company based in Ann Arbor (United States) founded in 2015 by Arul M Chinnaiyan. Standalone prostate cancer screening and COVID testing are provided. LynxDx offers products and services including MyProstateScore 2.0 and At-Home Sample Collection. Its focus areas include Clinical Laboratories. Its legal entity is Lynx Dx, Inc.
Company details
LynxDx was established in 2015 in Ann Arbor, United States, by founder Arul M. Chinnaiyan. Focus is placed on standalone centers for prostate cancer screening and COVID-19 testing within the healthcare diagnostics sector. Services are delivered through independent facilities, emphasizing accessible screening options. Operations are managed via the domain lynxdx.com, serving regional needs in medical testing and early detection.
- Headquarters Ann Arbor, United States
- Founders Arul M Chinnaiyan
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lynxdx.com
- Social LinkedIn X Facebook YouTube
- Legal Name Lynx Dx, Inc
- Latest Funding Round$2M (USD), Grant
Sep 2020
- Investors
Products & Services of LynxDx
LynxDx offers a comprehensive portfolio of products and services, including MyProstateScore 2.0 and At-Home Sample Collection.
A urine-based test is employed to assess prostate cancer risk by examining 18 gene transcripts and integrating clinical factors for personalized results.
Sample collection services are offered at home to facilitate the use of MyProstateScore 2.0, ensuring accessibility for patients undergoing risk assessments.
Apps and channels of LynxDx
its YouTube channel Lynx Dx has 13 subscribers and 16 videos.
Videos from LynxDx
The most watched videos on LynxDx's YouTube channel, Lynx Dx (13 subscribers). Click a video to play it here.
More on Lynx Dx.
Funding Insights of LynxDx
- Total Rounds 1
- Last Round Grant — $2M
- First Round $2M
(Sep 2020)
- Investors Count 1
All 1 funding rounds of LynxDx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $2M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in LynxDx
LynxDx has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for LynxDx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LynxDx
27 people are tracked at LynxDx (14 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Arul M Chinnaiyan | Founder | Leadership |
Jack Atchason | Vice President, Sales | Leadership |
Paul Graves | Vice President Of Finance And Human Resources | Leadership |
Matt Martin | Chief Financial Officer | Leadership |
Jeff Crays | Chief Technology Officer | Leadership |
Spencer Heaton | Chief Medical And Commercial Officer | Leadership |
Shawn Wheeler | Vice President, Market Access | Leadership |
Steve Riggs | President | Leadership |
John Kitchen | Medical Director | Leadership |
Rebecca Throop | Vice President, Marketing And Public Relations | Leadership |
Jacob Meyers | Director Of Research And Development | Leadership |
Eunice Ko | Regional Sales Director | Leadership |
Teresa Papadelis | Director Of Key Accounts | Leadership |
Ken Disney | Director Of Operations | Leadership |
Russell Bartnicki | Supply Chain Specialist Supervisor | Team |
Susan Rae Dravo | Key Account Manager | Team |
Todd Gruszka | Key Account Manager | Team |
Shannon Kelley | General Molecular Supervisor | Team |
Mary Michels | Human Resource Generalist | Team |
Antoine Washington | Accessioner | Team |
7 more people are available in the full profile.
Complete people profiles for LynxDx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LynxDx
2 dated milestones of LynxDx across 5 years, from founding to its latest funding, stage changes and deals.
- Founded LynxDx is founded.
- Funding First funding round of $2.0M.
Web traffic of LynxDx
The website of LynxDx (lynxdx.com) receives about 8.5K visits a month.
- Monthly visits8.5K
▲ 81.2% vs previous month
Websites whose visitors overlap most with LynxDx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pfizerforall.com | 100% | #519,521 | View details | ||
| pcf.org | 76% | 64.7K | #581,321 | View details | |
rinvoq.com | rinvoq.com | 76% | #92,673 | – | |
faqsstreet.com | faqsstreet.com | 76% | #46,654 | – |
Top companies in Diagnostics Laboratories
2 companies that operate in the same segment as LynxDx (Diagnostics Laboratories) in United States, ranked by their profile score on The Company Check.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LynxDx
LynxDx was founded in 2015 and raised its 1st funding round 5 years after it was founded.
LynxDx is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
LynxDx was established in 2015 in Ann Arbor, United States, by founder Arul M. Chinnaiyan. Focus is placed on standalone centers for prostate cancer screening and COVID-19 testing within the healthcare diagnostics sector. Services are delivered through independent facilities, emphasizing accessible screening options. Operations are managed via the domain lynxdx.com, serving regional needs in medical testing and early detection.
LynxDx offers MyProstateScore 2.0 and At-Home Sample Collection.
LynxDx has 1 investor. Key investors include HHS.
LynxDx operates through Lynx Dx, Inc.